RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Inter Pharma PCL Stock

Inter Pharma PCL Equity 2024

Inter Pharma PCL Equity

1.91 B THB

Ticker

IP.BK

ISIN

TH9474010005

In 2024, Inter Pharma PCL's equity was 1.91 B THB, a -0.68% increase from the 1.93 B THB equity in the previous year.

Inter Pharma PCL Aktienanalyse

What does Inter Pharma PCL do?

Inter Pharma PCL ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Inter Pharma PCL's Equity

Inter Pharma PCL's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Inter Pharma PCL's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Inter Pharma PCL's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Inter Pharma PCL's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Inter Pharma PCL’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Inter Pharma PCL stock

What is the equity of Inter Pharma PCL this year?

Inter Pharma PCL has equity of 1.91 B THB this year.

What was the equity of Inter Pharma PCL compared to the previous year?

The equity of Inter Pharma PCL has increased/decreased by -0.68% decreased compared to the previous year.

What impact does a high equity have on investors of Inter Pharma PCL?

A high equity is advantageous for investors of Inter Pharma PCL as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Inter Pharma PCL?

A low equity can be a risk for investors of Inter Pharma PCL, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Inter Pharma PCL affect the company?

An increase in equity of Inter Pharma PCL can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Inter Pharma PCL affect the company?

A reduction in equity of Inter Pharma PCL can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Inter Pharma PCL?

Some factors that can affect the equity of Inter Pharma PCL include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Inter Pharma PCL so important for investors?

The equity of Inter Pharma PCL is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Inter Pharma PCL take to change the equity?

To change equity, Inter Pharma PCL can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Inter Pharma PCL pay?

Over the past 12 months, Inter Pharma PCL paid a dividend of 0.18 THB . This corresponds to a dividend yield of about 3.67 %. For the coming 12 months, Inter Pharma PCL is expected to pay a dividend of 0.18 THB.

What is the dividend yield of Inter Pharma PCL?

The current dividend yield of Inter Pharma PCL is 3.67 %.

When does Inter Pharma PCL pay dividends?

Inter Pharma PCL pays a quarterly dividend. This is distributed in the months of May, April, June, June.

How secure is the dividend of Inter Pharma PCL?

Inter Pharma PCL paid dividends every year for the past 2 years.

What is the dividend of Inter Pharma PCL?

For the upcoming 12 months, dividends amounting to 0.18 THB are expected. This corresponds to a dividend yield of 3.67 %.

In which sector is Inter Pharma PCL located?

Inter Pharma PCL is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Inter Pharma PCL kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Inter Pharma PCL from 5/24/2024 amounting to 0.021 THB, you needed to have the stock in your portfolio before the ex-date on 5/7/2024.

When did Inter Pharma PCL pay the last dividend?

The last dividend was paid out on 5/24/2024.

What was the dividend of Inter Pharma PCL in the year 2023?

In the year 2023, Inter Pharma PCL distributed 0 THB as dividends.

In which currency does Inter Pharma PCL pay out the dividend?

The dividends of Inter Pharma PCL are distributed in THB.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Inter Pharma PCL

Our stock analysis for Inter Pharma PCL Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Inter Pharma PCL Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.